News

American Society of Hematology (ASH) 2017 – Oral Presentation

December 6, 2017

High Frequency of CD74 Expression in B-cell Non-Hodgkin’s Lymphoma (NHL) and Targeting with STRO-001, a Novel Anti-CD74 Antibody Drug Conjugate (ADC) with Potent In Vitro Cytotoxicity and In Vivo Anti-Tumor Activity

2017 ASH NHL Oral Presentation_2017 FINAL